Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kantil Pharmaceuticals, the trading name for Kantilal & Co., is a major Indian pharmaceutical exporter and wholesaler headquartered in Mumbai. Established in 1970, the company specializes in the global distribution of high-value, life-saving medications across therapeutic areas such as oncology, virology, and nephrology. They act as a strategic sourcing partner for international healthcare providers, offering both branded products from multinational corporations and high-quality generic alternatives. The firm is particularly noted for its robust supply chain capabilities, including specialized cold chain logistics for sensitive biologics. Kantil Pharmaceuticals serves a diverse global clientele, including hospitals, pharmacies, and government institutions. Their business model focuses on increasing the accessibility and affordability of critical healthcare treatments worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kantil Pharmaceuticals.